Stevens Capital Management LP purchased a new position in shares of MedEquities Realty Trust Inc. (NYSE:MRT) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 18,825 shares of the financial services provider’s stock, valued at approximately $221,000. Stevens Capital Management LP owned about 0.06% of MedEquities Realty Trust as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Eqis Capital Management Inc. acquired a new position in shares of MedEquities Realty Trust during the second quarter worth approximately $153,000. Raymond James Financial Services Advisors Inc. acquired a new position in shares of MedEquities Realty Trust during the second quarter worth approximately $154,000. UBS Group AG lifted its holdings in shares of MedEquities Realty Trust by 190.0% during the first quarter. UBS Group AG now owns 13,504 shares of the financial services provider’s stock worth $151,000 after buying an additional 8,847 shares during the last quarter. Acadian Asset Management LLC acquired a new position in shares of MedEquities Realty Trust during the second quarter worth approximately $175,000. Finally, Alliancebernstein L.P. acquired a new position in shares of MedEquities Realty Trust during the second quarter worth approximately $175,000. Institutional investors own 96.61% of the company’s stock.

Shares of MedEquities Realty Trust Inc. (MRT) opened at $11.23 on Wednesday. The stock has a market capitalization of $347.09, a P/E ratio of 9.94 and a beta of -0.70. MedEquities Realty Trust Inc. has a 1 year low of $10.06 and a 1 year high of $13.06.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 29th. Stockholders of record on Wednesday, November 15th will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 7.48%. The ex-dividend date of this dividend is Tuesday, November 14th. MedEquities Realty Trust’s dividend payout ratio is presently 210.01%.

MRT has been the subject of a number of research analyst reports. KeyCorp set a $13.00 price target on MedEquities Realty Trust and gave the stock a “buy” rating in a report on Sunday, October 29th. B. Riley restated a “buy” rating on shares of MedEquities Realty Trust in a research report on Wednesday, November 8th. Cantor Fitzgerald began coverage on MedEquities Realty Trust in a research report on Thursday, August 31st. They set an “overweight” rating and a $14.00 price objective on the stock. Capital One Financial Corporation restated an “equal weight” rating on shares of MedEquities Realty Trust in a research report on Sunday, October 22nd. Finally, Zacks Investment Research upgraded MedEquities Realty Trust from a “sell” rating to a “hold” rating and set a $12.00 price objective on the stock in a research report on Wednesday, November 15th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company. MedEquities Realty Trust presently has an average rating of “Hold” and a consensus price target of $12.83.

TRADEMARK VIOLATION WARNING: “Stevens Capital Management LP Purchases Shares of 18,825 MedEquities Realty Trust Inc. (MRT)” was published by Watch List News and is the property of of Watch List News. If you are reading this piece on another website, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece can be accessed at https://www.watchlistnews.com/stevens-capital-management-lp-purchases-shares-of-18825-medequities-realty-trust-inc-mrt/1719376.html.

In related news, Director Randy L. Churchey purchased 5,300 shares of the stock in a transaction on Monday, November 20th. The shares were purchased at an average cost of $10.87 per share, for a total transaction of $57,611.00. Following the completion of the transaction, the director now directly owns 46,776 shares of the company’s stock, valued at approximately $508,455.12. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO John W. Mcroberts purchased 18,000 shares of the stock in a transaction on Friday, November 17th. The stock was bought at an average price of $10.74 per share, for a total transaction of $193,320.00. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 23,600 shares of company stock worth $254,129. 2.50% of the stock is currently owned by company insiders.

About MedEquities Realty Trust

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Want to see what other hedge funds are holding MRT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MedEquities Realty Trust Inc. (NYSE:MRT).

Institutional Ownership by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.